- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Stable Growth Stocks
Global Pharmaceuticals & Biotech Stable Growth Stocks
Results
80
80 companies
Novartis
Market Cap: CHF 200.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 104.48
7D
1.6%
1Y
12.0%
PharmaResearch
Market Cap: ₩4.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩470,000.00
7D
2.0%
1Y
137.4%
Merck
Market Cap: US$259.7b
Operates as a healthcare company worldwide.
MRK
US$104.83
7D
7.2%
1Y
3.1%
Catalyst Pharmaceuticals
Market Cap: US$2.9b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$23.41
7D
0.6%
1Y
6.1%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.6b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س151.00
7D
0.8%
1Y
-3.9%
Incyte
Market Cap: US$20.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$104.46
7D
2.4%
1Y
40.0%
Genmab
Market Cap: DKK 125.6b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,039.00
7D
3.6%
1Y
33.6%
Lupin
Market Cap: ₹950.5b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,081.00
7D
2.6%
1Y
1.5%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$35.29
7D
2.9%
1Y
1.8%
WuXi AppTec
Market Cap: CN¥270.7b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥91.19
7D
-0.7%
1Y
81.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹434.8b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,566.65
7D
2.8%
1Y
4.9%
Pfizer
Market Cap: ₹227.6b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,975.00
7D
-0.5%
1Y
-6.4%
Torrent Pharmaceuticals
Market Cap: ₹1.3t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,721.70
7D
0.9%
1Y
11.9%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥17.7b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥71.89
7D
5.4%
1Y
21.3%
ChemoMetec
Market Cap: DKK 13.6b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 782.50
7D
4.1%
1Y
65.2%
Otsuka Holdings
Market Cap: JP¥4.7t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥8,846.00
7D
3.3%
1Y
1.9%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥40.5b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥65.70
7D
3.7%
1Y
186.9%
Jiangsu Hengrui PharmaceuticalsLtd
Market Cap: CN¥412.6b
A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
600276
CN¥62.08
7D
4.3%
1Y
22.5%
Shanghai Haoyuan Chemexpress
Market Cap: CN¥16.1b
Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.
688131
CN¥76.01
7D
4.4%
1Y
102.8%
Medpace Holdings
Market Cap: US$16.7b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$592.46
7D
0.1%
1Y
73.9%
Asymchem Laboratories (Tianjin)
Market Cap: CN¥32.7b
Asymchem Laboratories (Tianjin) Co., Ltd.
002821
CN¥92.75
7D
3.6%
1Y
10.5%
H. Lundbeck
Market Cap: DKK 42.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 44.42
7D
0.5%
1Y
1.0%
Stevanato Group
Market Cap: US$6.4b
Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
STVN
US$23.36
7D
4.4%
1Y
16.6%
ADMA Biologics
Market Cap: US$4.6b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$19.18
7D
11.6%
1Y
-4.6%
AstraZeneca
Market Cap: UK£216.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£139.74
7D
1.1%
1Y
31.7%
Exelixis
Market Cap: US$11.9b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$44.17
7D
3.9%
1Y
21.1%
ACADIA Pharmaceuticals
Market Cap: US$4.2b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$25.04
7D
6.3%
1Y
53.4%
Livzon Pharmaceutical Group
Market Cap: CN¥29.3b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥35.55
7D
0.2%
1Y
-6.9%
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥16.5b
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
300357
CN¥31.49
7D
5.0%
1Y
38.0%
Cipla
Market Cap: ₹1.2t
Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,531.30
7D
1.3%
1Y
-0.2%
3SBio
Market Cap: HK$74.8b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$31.26
7D
6.5%
1Y
446.5%
Krka d. d
Market Cap: €6.2b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€204.00
7D
0%
1Y
48.4%
AstraZeneca Pharma India
Market Cap: ₹226.2b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,048.30
7D
0.6%
1Y
37.9%
Merck KGaA
Market Cap: €50.4b
Operates as a science and technology company in Germany and internationally.
MRK
€116.00
7D
3.3%
1Y
-18.1%
Mettler-Toledo International
Market Cap: US$30.2b
Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
MTD
US$1,476.72
7D
1.7%
1Y
18.0%
Johnson & Johnson
Market Cap: US$498.5b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$206.92
7D
1.5%
1Y
33.5%